# Mice carrying a GluN2B protein-truncating variant have altered NMDA receptor subunit composition and their behavior recapitulates patient phenotypes

**Authors:** Klevinda Fili, Viktor Kuchtiak, Eni Tomovic, Miriam Candelas Serra, Agnieszka Kubik-Zahorodna, Karel Harant, Paulina Bozikova, Jiri Cerny, Miloslav Korinek, Barbora Hrcka Krausova, Vera Abramova, Mark Dobrovolski, Fatma Elzahraa S. Abdel Rahman, Jan Prochazka, Ales Balik, Tereza Smejkalova, Ladislav Vyklicky

PMC · DOI: 10.1007/s00018-025-06057-1 · Cellular and Molecular Life Sciences: CMLS · 2026-01-30

## TL;DR

Mice with a GluN2B mutation show changes in brain receptor function and behavior similar to human patients with intellectual disability.

## Contribution

A novel mouse model reveals how a GluN2B protein-truncating variant affects NMDA receptor composition and behavior.

## Key findings

- Reduced full-length GluN2B protein and increased GluN2A were observed in the mouse model.
- Behavioral changes included hypoactivity, increased anxiety in males, and impaired sensorimotor gating.
- Altered NMDA receptor function was consistent with a shift toward GluN2A-containing receptors.

## Abstract

Pathogenic variants in GRIN2B, encoding the NMDA receptor (NMDAR) GluN2B subunit, are linked to intellectual disability (ID) and related neurodevelopmental disorders. While most disease-associated variants are missense, protein-truncating variants (PTVs) may cause haploinsufficiency with less severe phenotypes. Here, we characterize a knock-in mouse model carrying the GluN2B-L825Ffs*15 PTV (Grin2b+/Δ). Proteomic analysis revealed markedly reduced full-length GluN2B protein and no detectable truncated GluN2B, accompanied by a small compensatory increase in GluN2A. Electrophysiology in hippocampal neurons demonstrated reduced NMDA-induced currents, diminished ifenprodil sensitivity, and accelerated NMDAR-mediated EPSC deactivation, consistent with a shift toward GluN2A-containing receptors. AMPAR-mEPSC amplitudes were increased, indicating altered excitatory synaptic function. Behaviorally, Grin2b+/Δ mice exhibited hypoactivity, increased anxiety in males, and impaired sensorimotor gating in both sexes, while learning, memory, and social behaviors remained largely intact. These results demonstrate that a monoallelic GluN2B PTV alters NMDAR subunit composition and function, producing moderate behavioral effects, and provide insight into mechanisms underlying GRIN2B-associated ID.

The online version contains supplementary material available at 10.1007/s00018-025-06057-1.

## Linked entities

- **Genes:** GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904]
- **Proteins:** GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A)
- **Diseases:** intellectual disability (MONDO:0001071)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Grin2b (glutamate receptor, ionotropic, NMDA2B (epsilon 2)) [NCBI Gene 14812] {aka GluN2B, GluRepsilon2, NR2B, Nmdar2b}, Gabrg2 (gamma-aminobutyric acid type A receptor, subunit gamma 2) [NCBI Gene 14406] {aka GABAA-R, Gabrg-2, gamma2}, Vmp1 (vacuole membrane protein 1) [NCBI Gene 75909] {aka 3110098I04Rik, 4930579A11Rik, Tango5, Tmem49, mir-21a, ni-2}, Grin2a (glutamate receptor, ionotropic, NMDA2A (epsilon 1)) [NCBI Gene 14811] {aka GluN2A, GluRepsilon1, NMDAR2A, NR2A}, Mt1 (metallothionein 1) [NCBI Gene 17748] {aka MT-I, Mt-1}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, Bace1 (beta-site APP cleaving enzyme 1) [NCBI Gene 23821] {aka ASP2, Bace}, B2m (beta-2 microglobulin) [NCBI Gene 12010] {aka Ly-m11, beta2-m, beta2m}, GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904] {aka DEE27, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Actl6b (actin-like 6B) [NCBI Gene 83766] {aka Actl6, ArpNa, Baf53b}, Bax (BCL2-associated X protein) [NCBI Gene 12028], GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A) [NCBI Gene 2903] {aka EPND, FESD, GluN2A, LKS, NMDAR2A, NR2A}, Cndp1 (carnosine dipeptidase 1) [NCBI Gene 338403] {aka Cn1}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) [NCBI Gene 2902] {aka DEE101, GluN1, MRD8, NDHMSD, NDHMSR, NMD-R1}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Drc4 (dynein regulatory complex subunit 4) [NCBI Gene 104346] {aka Gas11, Gas8}
- **Diseases:** working memory impairments (MESH:D008569), pancreatitis (MESH:D010195), hypoactivity (MESH:D020018), deficits (MESH:D009461), obsessive-compulsive disorder (MESH:D009771), cognitive deficits (MESH:D003072), sleep problems (MESH:D012893), fine motor skill deficits (MESH:D019957), shock (MESH:D012769), tumorigenesis (MESH:D063646), NMDA hypofunction (MESH:D000309), anxiety (MESH:D001007), ID (MESH:D008607), eEPSC (MESH:D020294), ATD (MESH:D007153), ABD (MESH:C563602), impaired sensorimotor gating (MESH:D020233), schizophrenia (MESH:D012559), PPR (MESH:D010411), aggressive behavior (MESH:D010554), behavioral abnormalities (MESH:D001523), TMD (MESH:D049310), HBSS (MESH:D013651), startle (MESH:D016750), epilepsy (MESH:D004827), DD (MESH:D002658), ASD (MESH:D000067877)
- **Chemicals:** EDTA (MESH:D004492), streptomycin (MESH:D013307), NH4Cl (MESH:D000643), CaCl2 (MESH:D002122), Triton X-100 (MESH:D017830), TCEP (MESH:C080938), PFA (MESH:C003043), NP-40 (MESH:C010615), Tween (MESH:D011136), penicillin (MESH:D010406), Laemmli buffer (MESH:C088816), EGTA (MESH:D004533), AMPA (MESH:D018350), TTX (MESH:D013779), digitonin (MESH:D004072), creatine phosphate (MESH:D010725), bicuculline methochloride (MESH:C006749), lysine (MESH:D008239), cholesterol (MESH:D002784), Ifenprodil (MESH:C010739), CO2 (MESH:D002245), KCl (MESH:D011189), water (MESH:D014867), chloroacetamide (MESH:C013874), NaCl (MESH:D012965), HEPES (MESH:D006531), Alexa Fluor 555 (MESH:C000608607), DOPC (MESH:C017251), o-phenylenediamine dihydrochloride (MESH:C034193), NBQX (MESH:C062865), NaOH (MESH:D012972), SDS (MESH:D012967), N-methyl-D-aspartate (MESH:D016202), Alexa Fluor 488 (MESH:C000711379), Glutamate (MESH:D018698), triethylammonium bicarbonate (MESH:C041737), sodium deoxycholate (MESH:D003840), agarose (MESH:D012685), salt (MESH:D012492), 4',6-diamidino-2-phenylindole (MESH:C007293), GlutaMAX (MESH:C054122), Kainate (MESH:D007608), KOH (MESH:C029943), glucose (MESH:D005947), Na+ (MESH:D012964), Cysteines (MESH:D003545), MgCl2 (MESH:D015636), methionine (MESH:D008715), 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (-), Cl- (MESH:D002713), metal (MESH:D008670), glycine (MESH:D005998), Alexa Fluor 647 (MESH:C569686)
- **Species:** Cercopithecidae (monkey, family) [taxon 9527], Rattus norvegicus (brown rat, species) [taxon 10116], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** leucine to phenylalanine, C456Y, L825V, L825Ffs*15-GFP, L825, L825Ffs*15, A - 2A, L825Ffs*15
- **Cell lines:** CRL-1573 — Sigmodon hispidus (Hispid cotton rat), Spontaneously immortalized cell line (CVCL_YD58), 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), African green monkey — Chlorocebus aethiops (Green monkey), Embryonic stem cell (CVCL_RY74), XL10 — Xenopus laevis (African clawed frog), Spontaneously immortalized cell line (CVCL_6743), COS-7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12876548/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12876548/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12876548/full.md

---
Source: https://tomesphere.com/paper/PMC12876548